TIME COURSE OF PHENOBARBITAL AND CIMETIDINE MEDIATED CHANGES IN HEPATIC DRUG-METABOLISM

被引:80
作者
DOSSING, M [1 ]
PILSGAARD, H [1 ]
RASMUSSEN, B [1 ]
POULSEN, HE [1 ]
机构
[1] RIGSHOSP,MED DEPT A,DIV HEPATOL,DK-2100 COPENHAGEN O,DENMARK
关键词
D O I
10.1007/BF00543794
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:215 / 222
页数:8
相关论文
共 43 条
[1]   INTRAINDIVIDUAL VARIATION IN DRUG DISPOSITION [J].
ALVARES, AP ;
KAPPAS, A ;
EISEMAN, JL ;
ANDERSON, KE ;
PANTUCK, CB ;
PANTUCK, EJ ;
HSIAO, KC ;
GARLAND, WA ;
CONNEY, AH .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1979, 26 (04) :407-419
[2]   DRUG-METABOLIZING CAPACITY IN STATES OF DRUG DEPENDENCE AND WITHDRAWAL [J].
BALLINGE.B ;
BROWNING, M ;
STEVENSO.IH .
BRITISH JOURNAL OF PHARMACOLOGY, 1972, 45 (04) :638-&
[3]   INHIBITION OF ANTIPYRINE METABOLISM BY BETA-ADRENOCEPTOR ANTAGONISTS [J].
BAX, NDS ;
LENNARD, MS ;
TUCKER, GT .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 12 (06) :779-784
[4]   EFFECTS OF CIMETIDINE AND RANITIDINE ON HEPATIC DRUG-METABOLISM [J].
BREEN, KJ ;
BURY, R ;
DESMOND, PV ;
MASHFORD, ML ;
MORPHETT, B ;
WESTWOOD, B ;
SHAW, RG .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1982, 31 (03) :297-300
[5]  
BREIMER DD, 1977, CLIN PHARMACOL THER, V21, P470
[6]   RIFAMPICIN AND VITAMIN-D METABOLISM [J].
BRODIE, MJ ;
BOOBIS, AR ;
DOLLERY, CT ;
HILLYARD, CJ ;
BROWN, DJ ;
MACINTYRE, I ;
PARK, BK .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 27 (06) :810-814
[7]   DRUG METABOLISM AND THERAPEUTICS [J].
CONNEY, AH ;
SPARK, RS ;
ROBINSON, SH ;
HIATT, HH ;
SCHNEIDER, P .
NEW ENGLAND JOURNAL OF MEDICINE, 1969, 280 (12) :653-&
[8]  
CONNEY AH, 1977, CLIN PHARM THER, V22, P706
[9]   DIFFERENTIAL-EFFECTS OF ENZYME-INDUCTION ON ANTIPYRINE METABOLITE FORMATION [J].
DANHOF, M ;
VERBEEK, RMA ;
VANBOXTEL, CJ ;
BOEIJINGA, JK ;
BREIMER, DD .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 13 (03) :379-386
[10]   STUDIES ON THE DIFFERENT METABOLIC PATHWAYS OF ANTIPYRINE IN MAN .1. ORAL-ADMINISTRATION OF 250, 500 AND 1000 MG TO HEALTHY-VOLUNTEERS [J].
DANHOF, M ;
BREIMER, DD .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 8 (06) :529-537